MARKET

ARMP

ARMP

Armata Pharmctcl
AMEX
2.220
-0.050
-2.20%
Closed 16:04 07/11 EDT
OPEN
2.290
PREV CLOSE
2.270
HIGH
2.290
LOW
2.219
VOLUME
3.70K
TURNOVER
6.51K
52 WEEK HIGH
3.415
52 WEEK LOW
0.8981
MARKET CAP
80.35M
P/E (TTM)
-20.9830
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARMP last week (0707-0711)?
Weekly Report · 1h ago
Weekly Report: what happened at ARMP last week (0630-0704)?
Weekly Report · 07/07 09:57
Weekly Report: what happened at ARMP last week (0623-0627)?
Weekly Report · 06/30 10:00
Weekly Report: what happened at ARMP last week (0616-0620)?
Weekly Report · 06/23 09:57
Weekly Report: what happened at ARMP last week (0609-0613)?
Weekly Report · 06/16 10:00
Armata Pharmaceuticals Elects Board Members at Annual Meeting
TipRanks · 06/13 20:43
Weekly Report: what happened at ARMP last week (0602-0606)?
Weekly Report · 06/09 10:00
Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma
Seeking Alpha · 06/08 19:19
More
About ARMP
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. The Company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. It is advancing two lead candidates, such as AP-PA02 and AP-SA02, to address both chronic and acute bacterial infections. Its lead phage candidate, inhaled AP-PA02, is focused primarily on the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.

Webull offers Armata Pharmaceuticals Inc stock information, including AMEX: ARMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARMP stock methods without spending real money on the virtual paper trading platform.